AXGN FY 2017 Earnings — AxoGen, Inc. Revenue & Financial Results | Market Cap Arena

AXGNAxoGen, Inc.

$2B

FY 2017 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$60M+47.0% YoY

Gross Profit

$51M84.6% margin

Operating Income

-$8M-13.2% margin

Net Income

-$10M-17.3% margin

EPS (Diluted)

$-0.31

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$11M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$59M

Total Liabilities

$34M

Stockholders' Equity

$25M

Cash & Equivalents

$37M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$60M	$41M	+47.0%
Gross Profit	$51M	$35M	+47.6%
Operating Income	-$8M	-$8M	+2.2%
Net Income	-$10M	-$14M	+27.5%